Bipolar Vaporisation of the Prostate (TURis) in Day-Case Surgery: A Series of 150 Cases

Introduction: Benign prostatic hyperplasia (BPH) is a common condition; nearly one third of patients require surgical treatment. Transurethral resection of the prostate (TURP) remains the reference standard, but its morbidity and hospital stay have driven the development of bipolar vaporisation in saline, which may allow same-day discharge. Objective: The primary objective was to assess the safety (complications graded according to the Clavien-Dindo classification and readmission) of TURis bipolar vaporisation performed as day-case surgery. Secondary objectives were functional outcomes at 1, 3 and 6 months and the feasibility of same-day discharge. Materials and Methods: This prospective single-centre study included 150 consecutive patients who underwent surgery over a 36-month period at Cheikh Khalifa Hospital, Casablanca. Eligibility for day-case surgery required, among other criteria, a home within 30 km of the hospital and the presence of a caregiver. The International Prostate Symptom Score (IPSS), maximum flow rate (Qmax) and post-void residual volume (PVR) were recorded preoperatively and at 1, 3 and 6 months and compared with baseline using a paired t-test (mean ± SD, 95% CI). Operative time, catheterisation time and complications were recorded. Results: Mean operative time was 45.3 minutes for a mean prostate volume of 63 g. Two cases of intraoperative haematuria (1.3%) occurred without transfusion. All patients were discharged on the day of surgery. The catheter was removed on postoperative day 1 in 100 patients (66.7%) and on day 2 in 50 (33.3%). Postoperative complications were classified as Clavien-Dindo grades I–II; the readmission rate was 2% and retention after catheter removal occurred in 14.7%. At 6 months, IPSS decreased from 20.3 ± 6.5 to 3.4 ± 1.7 (−83.3%), Qmax increased from 10.8 ± 3.6 to 20.6 ± 2.1 mL/s (+90.7%) and PVR decreased from 134 ± 65 to 18 ± 15.5 mL (−86.6%) (p < 0.001 for each parameter). Conclusion: In selected patients, day-case TURis bipolar vaporisation was feasible and safe, with significant improvement in symptoms and urinary flow parameters at 6 months. Comparative studies with longer follow-up are needed.

Authors

Institutions

Publication Details

Published
2026-11-16
DOI
https://doi.org/10.9734/ajrru/2026/v9i1183
Primary Topic
Urinary Bladder and Prostate Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Bipolar Vaporisation of the Prostate (TURis) in Day-Case Surgery: A Series of 150 Cases

Ghassane El Omri, Majid Boutaleb, Karim Boularbah, Abdeljalil Heddat et al.
Urinary Bladder and Prostate Research
article

Bipolar Vaporisation of the Prostate (TURis) in Day-Case Surgery: A Series of 150 Cases

Ghassane El Omri, Majid Boutaleb, Karim Boularbah, Abdeljalil Heddat, Rachid Moussaab, Younes Houry
article en

Abstract

Introduction: Benign prostatic hyperplasia (BPH) is a common condition; nearly one third of patients require surgical treatment. Transurethral resection of the prostate (TURP) remains the reference standard, but its morbidity and hospital stay have driven the development of bipolar vaporisation in saline, which may allow same-day discharge. Objective: The primary objective was to assess the safety (complications graded according to the Clavien-Dindo classification and readmission) of TURis bipolar vaporisation performed as day-case surgery. Secondary objectives were functional outcomes at 1, 3 and 6 months and the feasibility of same-day discharge. Materials and Methods: This prospective single-centre study included 150 consecutive patients who underwent surgery over a 36-month period at Cheikh Khalifa Hospital, Casablanca. Eligibility for day-case surgery required, among other criteria, a home within 30 km of the hospital and the presence of a caregiver. The International Prostate Symptom Score (IPSS), maximum flow rate (Qmax) and post-void residual volume (PVR) were recorded preoperatively and at 1, 3 and 6 months and compared with baseline using a paired t-test (mean ± SD, 95% CI). Operative time, catheterisation time and complications were recorded. Results: Mean operative time was 45.3 minutes for a mean prostate volume of 63 g. Two cases of intraoperative haematuria (1.3%) occurred without transfusion. All patients were discharged on the day of surgery. The catheter was removed on postoperative day 1 in 100 patients (66.7%) and on day 2 in 50 (33.3%). Postoperative complications were classified as Clavien-Dindo grades I–II; the readmission rate was 2% and retention after catheter removal occurred in 14.7%. At 6 months, IPSS decreased from 20.3 ± 6.5 to 3.4 ± 1.7 (−83.3%), Qmax increased from 10.8 ± 3.6 to 20.6 ± 2.1 mL/s (+90.7%) and PVR decreased from 134 ± 65 to 18 ± 15.5 mL (−86.6%) (p < 0.001 for each parameter). Conclusion: In selected patients, day-case TURis bipolar vaporisation was feasible and safe, with significant improvement in symptoms and urinary flow parameters at 6 months. Comparative studies with longer follow-up are needed.

Vol. 9(`1)
Hôpital Universitaire International Cheikh Khalifa (MA)
Good health and well-being
Urinary Bladder and Prostate Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon